Published in Women's Health Weekly, February 15th, 1999
S. Biesterfeld and colleagues from the University of Aachen, Germany, investigated the expression of EGF-R in the prognosis of squamous cell cervical carcinoma ("Absence of Epidermal Growth Factor Receptor Expression in Squamous Cell Carcinoma of the Uterine Cervix is an Indicator of Limited Tumor Disease," Oncology Reports, January-February 1999;6(1):205-209).
"The expression of growth factors is considered as an important diagnostic and prognostic feature in tumor pathology," wrote Biesterfeld et al. "We investigated the value of the immunohistochemical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.